Swiss National Bank Bluebird Bio, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$2.79 - $5.03 $26,226 - $47,282	9,400 Added 4.23%	231,600 $761,000
Q1 2023 May 10, 2023	BUY	$3.14 - $8.22 $113,040 - $295,920	36,000 Added 19.33%	222,200 $706,000
Q4 2022 Feb 08, 2023	BUY	$5.77 - $8.49 $1.07 Million - $1.58 Million	186,200 New	186,200 $1.29 Million
Q2 2022 Aug 09, 2022	SELL	$2.94 - $5.23 $487,472 - $867,170	-165,807 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.07 - $10.6 $67,969 - $177,020	16,700 Added 11.2%	165,807 $804,000
Q3 2021 Nov 08, 2021	BUY	$11.24 - $21.0 $12,364 - $23,100	1,100 Added 0.74%	149,107 $2.85 Million
Q2 2021 Aug 06, 2021	SELL	$18.04 - $22.09 $64,944 - $79,524	-3,600 Reduced 2.37%	148,007 $4.73 Million
Q1 2021 May 07, 2021	BUY	$16.59 - $33.89 $31,521 - $64,391	1,900 Added 1.27%	151,607 $4.57 Million
Q4 2020 Feb 05, 2021	BUY	$27.5 - $37.92 $82,500 - $113,760	3,000 Added 2.04%	149,707 $6.48 Million
Q3 2020 Nov 09, 2020	BUY	$34.44 - $43.75 $75,768 - $96,250	2,200 Added 1.52%	146,707 $7.92 Million
Q2 2020 Aug 05, 2020	BUY	$27.12 - $45.97 $1.01 Million - $1.71 Million	37,200 Added 34.67%	144,507 $8.82 Million
Q1 2020 May 08, 2020	BUY	$26.16 - $63.5 $41,856 - $101,600	1,600 Added 1.51%	107,307 $4.93 Million
Q4 2019 Feb 06, 2020	BUY	$46.96 - $61.67 $89,224 - $117,173	1,900 Added 1.83%	105,707 $9.28 Million
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $95,152 - $148,960	1,600 Added 1.57%	103,807 $9.53 Million
Q2 2019 Aug 02, 2019	BUY	$75.84 - $105.21 $197,184 - $273,546	2,600 Added 2.61%	102,207 $13 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $244,872 - $395,618	3,800 Added 3.97%	99,607 $15.7 Million
Q4 2018 Feb 13, 2019	BUY	$59.1 - $93.26 $159,570 - $251,802	2,700 Added 2.9%	95,807 $9.5 Million
Q3 2018 Nov 08, 2018	BUY	$88.86 - $117.49 $533,160 - $704,940	6,000 Added 6.89%	93,107 $13.6 Million
Q2 2018 Aug 09, 2018	BUY	$99.64 - $127.59 $129,532 - $165,867	1,300 Added 1.52%	87,107 $13.7 Million
Q1 2018 May 04, 2018	BUY	$105.8 - $150.94 $338,560 - $483,008	3,200 Added 3.87%	85,807 $14.7 Million
Q4 2017 Feb 07, 2018	BUY	$81.25 - $130.7 $617,500 - $993,319	7,600 Added 10.13%	82,607 $14.7 Million
Q3 2017 Nov 03, 2017	BUY	$57.74 - $91.42 $4.33 Million - $6.86 Million	75,007	75,007 $10.3 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account